PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk.
Breast cancer (BC) risk has been differentially associated with urinary levels of some phthalate metabolites. To investigate whether PPARγ and PPARGC1B polymorphisms modulate these associations. 208 BC cases were age-matched with 220 population controls. Phthalate metabolites were determined by HPLC-MS. PPARγ Pro12Ala (rs1801281) and PPARGC1B Ala203Pro (rs7732671) and Val279Ile (rs17572019) were genotyped. The association between mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and BC risk was positively modified in PPARγ Pro12Ala C carriers. The association with mono-iso-butyl phthalate (MiBP) in PPARGC1B Ala203Pro G carriers was negatively modified. PPARγ and PPARGC1B polymorphisms modulate the association between phthalate exposure and BC risk.